Prahsys is conducting an evaluation study for PrognosiX AI involving licensed dental professionals, with the FDA 510(k) submission in process.
Public source
Publisher name
Public post
The Next Standard in Clinical Confidence. Better information starts with better visibility. PrognosiX AI helps clinicians see anatomical detail already captured in their…
Company
Prahsys
AI lab developing clinical and administrative models to streamline healthcare.
- Industry
- Artificial Intelligence
- Location
- The Woodlands, US
- Company size
- 11–50 employees
About Prahsys
We're an AI development company that builds frictionless AI systems for healthcare. We help healthcare teams focus on patient care by embedding clinical and administrative AI into their existing workflows.
See moreLatest activity
Latest activity from Prahsys
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
Zentist
Zentist announced that Pearl launched Second Opinion 3D, a commercial product for general dentists using its FDA-cleared 3D imaging AI.
Legal & Regulatory
CareDocs.ai
CareDocs.ai adheres to guidelines ensuring safety and precision for compliance findings in clinical use.
Legal & Regulatory
RhythmX AI
RhythmX AI has been committed to clinical governance and validation for the past two years, with Merissa V. Hawkins providing two years of clinically validated outputs by a large panel of physicians.
Legal & Regulatory
CergenX
CergenX team announced that Wave, an AI-powered technology providing rapid, objective insights into newborn brain activity, has officially achieved CE Mark certification under EU MDR 2017/745.
Legal & Regulatory
Hippocratic AI